Ed

Before I do that, I want to remind our listeners, we have a weekly newsletter, Prof G Markets. It breaks down the key market moves with data-driven analysis and crisp visuals every Monday. So a reminder, please go subscribe now at profgmarkets.com. We'll also leave a link in the description of this episode to make it easy for you to sign up.

Before I do that, I want to remind our listeners, we have a weekly newsletter, Prof G Markets. It breaks down the key market moves with data-driven analysis and crisp visuals every Monday. So a reminder, please go subscribe now at profgmarkets.com. We'll also leave a link in the description of this episode to make it easy for you to sign up.

Before I do that, I want to remind our listeners, we have a weekly newsletter, Prof G Markets. It breaks down the key market moves with data-driven analysis and crisp visuals every Monday. So a reminder, please go subscribe now at profgmarkets.com. We'll also leave a link in the description of this episode to make it easy for you to sign up.

If you don't have time to listen to the podcast, this is a good way to sort of get your quick hit. in your inbox in the morning. So please go subscribe to that. And with that, let's get to the headlines. Pharmaceutical stocks dropped after Trump said he had a plan that would significantly slash drug prices in the US.

If you don't have time to listen to the podcast, this is a good way to sort of get your quick hit. in your inbox in the morning. So please go subscribe to that. And with that, let's get to the headlines. Pharmaceutical stocks dropped after Trump said he had a plan that would significantly slash drug prices in the US.

If you don't have time to listen to the podcast, this is a good way to sort of get your quick hit. in your inbox in the morning. So please go subscribe to that. And with that, let's get to the headlines. Pharmaceutical stocks dropped after Trump said he had a plan that would significantly slash drug prices in the US.

However, the stocks quickly rebounded after he signed an executive order that lacked any legal mandate for companies to bring down prices. Instead, the order asked them to lower prices voluntarily. AI startup Perplexity is in talks for a $500 million funding round that would value the company at $14 billion. That's more than 50% higher than its last valuation from just five months ago.

However, the stocks quickly rebounded after he signed an executive order that lacked any legal mandate for companies to bring down prices. Instead, the order asked them to lower prices voluntarily. AI startup Perplexity is in talks for a $500 million funding round that would value the company at $14 billion. That's more than 50% higher than its last valuation from just five months ago.

However, the stocks quickly rebounded after he signed an executive order that lacked any legal mandate for companies to bring down prices. Instead, the order asked them to lower prices voluntarily. AI startup Perplexity is in talks for a $500 million funding round that would value the company at $14 billion. That's more than 50% higher than its last valuation from just five months ago.

And finally, Coinbase shares rose more than 20% on news that the company will join the S&P 500. It will be the first digital asset company to be included in the index. So, Scott, let's start with what happened with pharmaceutical stocks. First, they dropped after Trump said that we're going to have this big price decrease plan on drugs in the U.S.

And finally, Coinbase shares rose more than 20% on news that the company will join the S&P 500. It will be the first digital asset company to be included in the index. So, Scott, let's start with what happened with pharmaceutical stocks. First, they dropped after Trump said that we're going to have this big price decrease plan on drugs in the U.S.

And finally, Coinbase shares rose more than 20% on news that the company will join the S&P 500. It will be the first digital asset company to be included in the index. So, Scott, let's start with what happened with pharmaceutical stocks. First, they dropped after Trump said that we're going to have this big price decrease plan on drugs in the U.S.

Then he signed the executive order and the stocks rebounded again. Your reactions?

Then he signed the executive order and the stocks rebounded again. Your reactions?

Then he signed the executive order and the stocks rebounded again. Your reactions?

Are you saying we need to cut spending on Medicare and Medicaid? What... What is your suggestion there in terms of how this all relates, how deficits relate to health care?

Are you saying we need to cut spending on Medicare and Medicaid? What... What is your suggestion there in terms of how this all relates, how deficits relate to health care?

Are you saying we need to cut spending on Medicare and Medicaid? What... What is your suggestion there in terms of how this all relates, how deficits relate to health care?

Just as an example of how crazy the prices are, there's this diabetes medication I was looking at called Jardiance. One month's supply costs $611 in America. In Japan, it costs $35. It's not as if everyone in Japan is poor in the prices. I mean, that's just an unbelievable... And again, the markets are telling us the true story here.

Just as an example of how crazy the prices are, there's this diabetes medication I was looking at called Jardiance. One month's supply costs $611 in America. In Japan, it costs $35. It's not as if everyone in Japan is poor in the prices. I mean, that's just an unbelievable... And again, the markets are telling us the true story here.